- Home
- TEVA vs PODD Comparison
TEVA vs PODD Comparison
Compare TEVA & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEVA
- PODD
- Stock Information
- Founded
- TEVA 1901
- PODD 2000
- Country
- TEVA Israel
- PODD United States
- Employees
- TEVA N/A
- PODD N/A
- Industry
- TEVA Biotechnology: Pharmaceutical Preparations
- PODD Medical/Dental Instruments
- Sector
- TEVA Health Care
- PODD Health Care
- Exchange
- TEVA Nasdaq
- PODD Nasdaq
- Market Cap
- TEVA 18.4B
- PODD 19.0B
- IPO Year
- TEVA N/A
- PODD 2007
- Fundamental
- Price
- TEVA $15.38
- PODD $262.61
- Analyst Decision
- TEVA Strong Buy
- PODD Buy
- Analyst Count
- TEVA 6
- PODD 17
- Target Price
- TEVA $24.00
- PODD $294.65
- AVG Volume (30 Days)
- TEVA 11.7M
- PODD 854.2K
- Earning Date
- TEVA 05-07-2025
- PODD 05-08-2025
- Dividend Yield
- TEVA N/A
- PODD N/A
- EPS Growth
- TEVA N/A
- PODD 96.55
- EPS
- TEVA N/A
- PODD 5.78
- Revenue
- TEVA $16,544,000,000.00
- PODD $2,071,600,000.00
- Revenue This Year
- TEVA $5.31
- PODD $20.58
- Revenue Next Year
- TEVA $1.18
- PODD $17.41
- P/E Ratio
- TEVA N/A
- PODD $45.23
- Revenue Growth
- TEVA 4.41
- PODD 22.07
- 52 Week Low
- TEVA $12.51
- PODD $160.19
- 52 Week High
- TEVA $22.80
- PODD $289.46
- Technical
- Relative Strength Index (RSI)
- TEVA 38.74
- PODD 48.11
- Support Level
- TEVA $15.28
- PODD $255.76
- Resistance Level
- TEVA $15.80
- PODD $276.13
- Average True Range (ATR)
- TEVA 0.52
- PODD 8.32
- MACD
- TEVA -0.01
- PODD 0.80
- Stochastic Oscillator
- TEVA 30.41
- PODD 62.70
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it world-wide.